ATE165509T1 - Avermectine und milbemycine zur behandlung von parazitären infektionen beim hund - Google Patents

Avermectine und milbemycine zur behandlung von parazitären infektionen beim hund

Info

Publication number
ATE165509T1
ATE165509T1 AT91919873T AT91919873T ATE165509T1 AT E165509 T1 ATE165509 T1 AT E165509T1 AT 91919873 T AT91919873 T AT 91919873T AT 91919873 T AT91919873 T AT 91919873T AT E165509 T1 ATE165509 T1 AT E165509T1
Authority
AT
Austria
Prior art keywords
dogs
paracitic
avermectine
milbemycine
infections
Prior art date
Application number
AT91919873T
Other languages
English (en)
Inventor
John Dick Hood
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Application granted granted Critical
Publication of ATE165509T1 publication Critical patent/ATE165509T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365Lactones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Saccharide Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
AT91919873T 1990-11-16 1991-11-11 Avermectine und milbemycine zur behandlung von parazitären infektionen beim hund ATE165509T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB909024927A GB9024927D0 (en) 1990-11-16 1990-11-16 Novel treatment

Publications (1)

Publication Number Publication Date
ATE165509T1 true ATE165509T1 (de) 1998-05-15

Family

ID=10685475

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91919873T ATE165509T1 (de) 1990-11-16 1991-11-11 Avermectine und milbemycine zur behandlung von parazitären infektionen beim hund

Country Status (15)

Country Link
US (1) US5643886A (de)
EP (1) EP0557348B1 (de)
JP (1) JP3009463B2 (de)
KR (1) KR930701996A (de)
AT (1) ATE165509T1 (de)
AU (2) AU660429B2 (de)
CA (1) CA2096345C (de)
DE (1) DE69129334T2 (de)
DK (1) DK0557348T3 (de)
ES (1) ES2114893T3 (de)
GB (1) GB9024927D0 (de)
IE (1) IE913971A1 (de)
NZ (1) NZ240588A (de)
WO (1) WO1992008455A1 (de)
ZA (1) ZA919021B (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2753377B1 (fr) * 1996-09-19 1999-09-24 Rhone Merieux Nouvelle association parasiticide a base de 1-n-phenylpyra- zoles et de lactones macrocycliques endectocides
DE102004053964A1 (de) 2004-11-09 2006-05-11 Bayer Healthcare Ag Mittel gegen Demodikose

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2054664T3 (es) * 1986-03-12 1994-08-16 American Cyanamid Co Compuestos macrolidos.
US4849446A (en) * 1986-09-12 1989-07-18 American Cyanamid Company 23-imino derivatives of 23-keto compounds
EP0260537A1 (de) * 1986-09-12 1988-03-23 American Cyanamid Company 13-Deoxy-23-oxo(keto)- und 23-imino-Derivate von 13-Deoxy-C-076-aglykon-Verbindungen
DE3750355T2 (de) * 1986-09-12 1995-04-06 American Cyanamid Co 23-Oxo(keto) und 23-Imino-Derivate von LL-F28249-Verbindungen.
NZ233680A (en) * 1989-05-17 1995-02-24 Beecham Group Plc Avermectins and milbemycins and compositions thereof

Also Published As

Publication number Publication date
JPH06502405A (ja) 1994-03-17
KR930701996A (ko) 1993-09-08
CA2096345A1 (en) 1992-05-17
ES2114893T3 (es) 1998-06-16
DE69129334D1 (de) 1998-06-04
AU3295495A (en) 1995-11-30
JP3009463B2 (ja) 2000-02-14
IE913971A1 (en) 1992-05-20
CA2096345C (en) 2000-10-31
US5643886A (en) 1997-07-01
ZA919021B (en) 1992-09-30
NZ240588A (en) 1994-12-22
AU688105B2 (en) 1998-03-05
GB9024927D0 (en) 1991-01-02
DK0557348T3 (da) 1998-10-07
EP0557348B1 (de) 1998-04-29
AU660429B2 (en) 1995-06-29
AU8865891A (en) 1992-06-11
WO1992008455A1 (en) 1992-05-29
EP0557348A1 (de) 1993-09-01
DE69129334T2 (de) 1998-08-20

Similar Documents

Publication Publication Date Title
ATE211925T1 (de) Behandlung von material
ATE139447T1 (de) Mittel zur verstaerkung der wirkung von antitumoralen mittel und zur widerstandsbekaempfung von vielfachdrogen
RU94031102A (ru) Сульфамиды в качестве антагонистов эндотелина и способ лечения соответствующих заболеваний
ATE313326T1 (de) VERWENDUNG VON CABERGOLIN ZUR BEHANDLUNG VON ßRESTLESS LEGS SYNDROMß
ATE225176T1 (de) Verwendung von serotonin-antagonisten (5ht3) zur behandlung von fibromyalgie
FR2786664B1 (fr) Procede de traitement de fruits et legumes utilisant l'eugenol et/ou l'isoeugenol et utilisation d'une composition a base d'eugenol et/ou d'isoeugenol
DE69116380D1 (de) Pharmazeutische zubereitung zur behandlung verlängerter gerinnungszeit
DE69013880D1 (de) Verfahren und Vorrichtung zur Behandlung von Absorptionssuspensionen, die Flugasche beinhalten.
DE69008258D1 (de) S-adenosylmethionin zur behandlung von pankreatitis und der immunabstossung des pankreastransplantates.
ID24184A (id) Obat untuk perawatan disfungsi ereksi
ATE222101T1 (de) Verwendung von selegilin oder desmethylselegilin zur behandlung von wunden, verbrennungen und hautschäden
ATE190839T1 (de) Verwendung von prodelphidinen zur behandlung von arthrose
DE69626816D1 (de) Verwendung von selegilin zur behandlung von gehörverlust bei säugetieren
ATE165509T1 (de) Avermectine und milbemycine zur behandlung von parazitären infektionen beim hund
DE58902451D1 (de) (s)-emopamil zur anwendung bei der behandlung von migraene.
DE69424679D1 (de) Zusammensetzung zur behandlung oder vorbeugung von herpes
ATE128871T1 (de) Verfahren zur behandlung von thrombocytopenie und dafür geeignete pharmazeutische zusammensetzungen.
DE60109594D1 (de) R-eliprodil zur behandlung von glaucoma
ATE236633T1 (de) Topische verwendung von loperamid zur behandlung mikrobieller infektionen
DE69427116D1 (de) Verwendung von 4'-iodo - 4 - deoxydoxorubicin zur behandlung von amyloidosis
DE69936779D1 (de) Verwendung von ngali nussöl zur behandlung/linderung der arthritisschmerzen und anderer ähnlichen störungen
ATA48390A (de) Vorrichtung zur behandlung, insbesondere zur reinigung, von oberflaechen
DE59410340D1 (de) Verwendung von Bradykinin-Antagonisten zur Behandlung von Viruserkrankungen
SE9403861D0 (sv) Novel medicinal use
ATE214923T1 (de) Verwendung von (r)-verapamil als medizin zur behandlung von angina

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee